These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
646 related articles for article (PubMed ID: 23186319)
21. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700 [TBL] [Abstract][Full Text] [Related]
22. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades. Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754 [TBL] [Abstract][Full Text] [Related]
23. Relevance of CD38 expression on CD8 T cells to evaluate antiretroviral therapy response in HIV-1-infected youths. Rosso R; Fenoglio D; Terranova MP; Lantieri F; Risso D; Pontali E; Setti M; Cossarizza A; Ravetti JL; Viscoli C; Kunkl A Scand J Immunol; 2010 Jan; 71(1):45-51. PubMed ID: 20017809 [TBL] [Abstract][Full Text] [Related]
24. Immunophenotype of HIV+ patients during CD4 cell-monitored treatment interruption: role of the IL-7/IL-7 receptor system. Nemes E; Lugli E; Nasi M; Ferraresi R; Pinti M; Bugarini R; Borghi V; Prati F; Esposito R; Cossarizza A; Mussini C AIDS; 2006 Oct; 20(16):2021-32. PubMed ID: 17053348 [TBL] [Abstract][Full Text] [Related]
25. Characterizing the immune system after long-term undetectable viral load in HIV-1-infected children. Resino S; Galán I; Bellón JM; Navarro ML; León JA; Muñoz-Fernandez MA J Clin Immunol; 2003 Jul; 23(4):279-89. PubMed ID: 12959220 [TBL] [Abstract][Full Text] [Related]
26. T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection. Eggena MP; Barugahare B; Okello M; Mutyala S; Jones N; Ma Y; Kityo C; Mugyenyi P; Cao H J Infect Dis; 2005 Mar; 191(5):694-701. PubMed ID: 15688282 [TBL] [Abstract][Full Text] [Related]
27. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART. Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy. Benito JM; López M; Lozano S; González-Lahoz J; Soriano V J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371 [TBL] [Abstract][Full Text] [Related]
29. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery. Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642 [TBL] [Abstract][Full Text] [Related]
30. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients. Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174 [TBL] [Abstract][Full Text] [Related]
31. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy. d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625 [TBL] [Abstract][Full Text] [Related]
32. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses. Lichtenstein KA; Armon C; Nagabhushanam V; Efaw BJ; Frazer-Abel A; Hiserote ME; Alam R Antivir Ther; 2012; 17(7):1301-9. PubMed ID: 22948290 [TBL] [Abstract][Full Text] [Related]
33. Dynamics of T cells subsets and lymphoproliferative responses during structured treatment interruption cycles and after definitive interruption of HAART in early chronic HIV type-1-infected patients. Libois A; López A; Garcia F; Castro P; Maleno MJ; García A; Climent N; Arnedo M; Gallart T; Gatell JM; Plana M AIDS Res Hum Retroviruses; 2006 Jul; 22(7):657-66. PubMed ID: 16831090 [TBL] [Abstract][Full Text] [Related]
34. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection. Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071 [TBL] [Abstract][Full Text] [Related]
35. Expression levels of P-glycoprotein in peripheral blood CD8+ T lymphocytes from HIV-1-infected patients on antiretroviral therapy. Zhang JC; Xie F; Yu XH; Deng ZY; Wang Y; Liang P; Sun L; Zhang FX Int J Mol Med; 2014 Feb; 33(2):431-40. PubMed ID: 24337436 [TBL] [Abstract][Full Text] [Related]
36. Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes, increased pools of naive T cells, decreased pools of activated T cells, and diminished frequencies of peripheral activated HIV type 1-specific CD8+ T cells. Gray CM; Lawrence J; Ranheim EA; Vierra M; Zupancic M; Winters M; Altman J; Montoya J; Zolopa A; Schapiro J; Haase AT; Merigan TC AIDS Res Hum Retroviruses; 2000 Sep; 16(14):1357-69. PubMed ID: 11018855 [TBL] [Abstract][Full Text] [Related]
37. [The correlation of HIV-1 viral load to expression of CD8+ T lymphocyte activators CD38 and HLA-DR]. Han Y; Qiu ZF; Li TS; Xie J; Zuo LY; Kuang JQ; Wang AX Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):459-62. PubMed ID: 16831321 [TBL] [Abstract][Full Text] [Related]
38. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases. Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519 [TBL] [Abstract][Full Text] [Related]
39. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. Bouscarat F; Levacher-Clergeot M; Dazza MC; Strauss KW; Girard PM; Ruggeri C; Sinet M AIDS Res Hum Retroviruses; 1996 Jan; 12(1):17-24. PubMed ID: 8825614 [TBL] [Abstract][Full Text] [Related]
40. Poor lymphoproliferative responses with low proportion of Gag-specific CD8 TEMRA cells in HIV-1-infected patients showing immunological and virological discordance despite prolonged suppression of plasma viremia. Sachdeva N; Weinstein JE; Ashman M; Sachdeva M; Brewer TH; Gracia D; Asthana D Viral Immunol; 2010 Feb; 23(1):49-61. PubMed ID: 20121402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]